Tuberculosis vaccine's link to reduced dementia risk gains mechanistic support
Bacillus Calmette-Guerin (BCG), a vaccine widely used to prevent tuberculosis and treat bladder cancer, may also have properties that reduce the risk for dementia, according to new findings in a study of mice. BCG is a live, weakened vaccine made from an altered strain of the bacterium Mycobacterium bovis.
Read original article on Medical Xpress - latest medical and health news stories →